Beijing WeMed Medical completed a $46 million Series D financing to support its digital angiography products. The company makes interventional diagnosis and treatment devices. WeMed offers products that include a digital subtraction angiography (DSA) system, a mobile angiography system, surgical C-arms, and novel R&D for interventional surgical robots  The company says its DSA products are China equivalents to machines that are already available from international device makers, but its robot products offer novel technology. The Series D round was led by Lake Bleu Capital. More details.... Share this with colleagues: // //